Literature DB >> 7754533

Neuropeptide Y effector systems: perspectives for drug development.

L Grundemar1, R Håkanson.   

Abstract

Neuropeptide Y was isolated in 1982 and has since attracted considerable interest. It is widely distributed in central and peripheral neurones and can produce a multitude of biological effects in the brain and the periphery. For example, the peptide has been associated with stimulation of food and water intake, control of mood, and regulation of central autonomic functions. In the periphery, sympathetic neuropeptide Y plays a role as a vasopressor and vasoconstrictor. Neuropeptide Y acts on at least three distinct receptor types, referred to a Y1, Y2 and Y3. This review by Lars Grundemar and Rolf Håkanson focuses on some neuropeptide Y-dependent mechanisms that may be implicated in certain disorders and may be promising targets for drugs active at neuropeptide Y receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7754533     DOI: 10.1016/0165-6147(94)90076-0

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  18 in total

1.  Peptide self-association in aqueous trifluoroethanol monitored by pulsed field gradient NMR diffusion measurements.

Authors:  S Yao; G J Howlett; R S Norton
Journal:  J Biomol NMR       Date:  2000-02       Impact factor: 2.835

2.  Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release.

Authors:  C J Small; D G Morgan; K Meeran; M M Heath; I Gunn; C M Edwards; J Gardiner; G M Taylor; J D Hurley; M Rossi; A P Goldstone; D O'Shea; D M Smith; M A Ghatei; S R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms.

Authors:  X J Yu; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

4.  Solution structure of human neuropeptide Y.

Authors:  S A Monks; G Karagianis; G J Howlett; R S Norton
Journal:  J Biomol NMR       Date:  1996-12       Impact factor: 2.835

5.  Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.

Authors:  H Gicquiaux; M Tschöpl; H N Doods; B Bucher
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

Review 6.  Neuronal and non-neuronal modulation of sympathetic neurovascular transmission.

Authors:  H Macarthur; G H Wilken; T C Westfall; L L Kolo
Journal:  Acta Physiol (Oxf)       Date:  2011-03-01       Impact factor: 6.311

7.  Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum.

Authors:  Nathalie Thiriet; Xiaolin Deng; Marcello Solinas; Bruce Ladenheim; Wendy Curtis; Steven R Goldberg; Richard D Palmiter; Jean Lud Cadet
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

8.  Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats.

Authors:  Melanie Felies; Stephan von Hörsten; Reinhard Pabst; Heike Nave
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

Review 9.  Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

Review 10.  The insecticidal potential of venom peptides.

Authors:  Jennifer J Smith; Volker Herzig; Glenn F King; Paul F Alewood
Journal:  Cell Mol Life Sci       Date:  2013-03-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.